Jan 9 (Reuters) - Nasdaq on Friday said U.S. retailer Walmart will replace British drugmaker Astrazeneca in the Nasdaq-100 Index effective on January 20, 2026.
(Reporting by Rhea Rose Abraham in Bengaluru; Editing by Tom Hogue)
| Market Closed - Nasdaq 22:16:00 10/02/2026 GMT | 5-day change | 1st Jan Change | ||
| 23,102.47 PTS | -0.59% |
|
-0.66% | -0.60% |
| 11-21 | Vaneck BNB ETF shares expected to be approved for listing on Nasdaq | RE |
| 11-21 | Cheer Holding receives Nasdaq delisting notice subject to hearing request | RE |
Published on 01/10/2026 at 01:11 am GMT - Modified on 01/10/2026 at 01:16 am GMT
Jan 9 (Reuters) - Nasdaq on Friday said U.S. retailer Walmart will replace British drugmaker Astrazeneca in the Nasdaq-100 Index effective on January 20, 2026.
(Reporting by Rhea Rose Abraham in Bengaluru; Editing by Tom Hogue)

Select your edition
All financial news and data tailored to specific country editions